COPPER GLUCONATE is a copper salt of D-gluconic acid that displays a light blue to bluish-green color. It is prepared by the reaction of gluconic acid solutions with cupric oxide or basic cupric carbonate. According to the good manufacturing or feeding practice by the FDA, copper gluconate is used as a nutrient or dietary supplement and is generally recognized as safe for use at a level not exceeding 0.005 percent. Copper Gluconate can be used as a dietary supplement and as a nutrient. Copper aids in the absorption of iron, in the formation of red blood cells and the proper bone formation and maintenance.

VILDAGLIPTIN is an oral anti-hyperglycemic agent (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs.

 

Products still subject to third-party patent protection might be available solely for R&D purposes.

RACECADOTRIL is an antidiarrheal medication which acts as a peripheral enkephalinase inhibitor. RACECADOTRIL has an antisecretory effect - it reduces the secretion of water and electrolytes into the intestine.

 

Products still subject to third-party patent protection might be available solely for R&D purposes.

As a novel potassium-competitive acid blocker, VONOZOPRAN FUMARATE may provide reversible acid suppression by preventing K+ from binding to gastric H+/K+-ATPase. It has been clinically used for the short-term treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease and Helicobacter pylori (H. pylori) infection.

 

Products still subject to third-party patent protection might be available solely for R&D purposes.